Examining the impact of trauma and addiction treatment on PTSD and CPTSD
What's in a Name? Do PTSD and Complex PTSD Diagnoses Predict Differences in Course and Outcome of Integrated Addiction and Trauma Focused Treatment?
This study is testing how different trauma and addiction treatments work for people with PTSD compared to those with CPTSD to see if it makes a difference in their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IrisZorg Academic / other |
| Locations | 1 site (Arnhem) |
| Trial ID | NCT06588309 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the differences in treatment outcomes between patients with substance use disorders (SUD) who have comorbid PTSD and those with comorbid CPTSD. It will involve two groups of participants, each receiving integrated trauma-focused treatment alongside standard addiction care. Assessments will be conducted at various points to evaluate the effectiveness of the treatment approaches. The study seeks to clarify the clinical relevance of distinguishing between PTSD and CPTSD in addiction treatment settings.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a substance use disorder and a diagnosis of either PTSD or CPTSD who are proficient in Dutch.
Not a fit: Patients without a substance use disorder or those who do not meet the diagnostic criteria for PTSD or CPTSD may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for patients with comorbid PTSD or CPTSD and substance use disorders.
How similar studies have performed: While the differentiation between PTSD and CPTSD is established, the specific integrated treatment approach in this context is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years. •- Primary diagnosis SUD involving one of the following substances: alcohol, cannabis, cocaine, amphetamine, benzodiazepine, opioid according to the DSM-5 (American Psychiatric Association, 2013), who are receiving or starting outpatient CRA. * A DSM-5 diagnosis of PTSD (n=25). A DSM-5 diagnosis of PTSD and an additional ICD-11 diagnosis of CPTSD (n=25). * Planned start of EMDR-therapy within 8 weeks. * Good Dutch language proficiency (based on clinical judgement). * Written informed consent Exclusion Criteria: \-
Where this trial is running
Arnhem
- IrisZorg — Arnhem, Netherlands (Recruiting)
Study contacts
- Study coordinator: Angelique Dekkers, MSc.
- Email: angelique.dekkers@iriszorg.nl
- Phone: +31-886061463
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.